<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JAMA Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">JAMA Psychiatry</journal-id>
<journal-id journal-id-type="pmc">JAMA Psychiatry</journal-id>
<journal-title-group>
<journal-title>JAMA Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">2168-622X</issn>
<issn pub-type="epub">2168-6238</issn>
<publisher>
<publisher-name>American Medical Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28832883</article-id>
<article-id pub-id-type="pmc">5710217</article-id>
<article-id pub-id-type="doi">10.1001/jamapsychiatry.2017.2604</article-id>
<article-id pub-id-type="publisher-id">yoi170065</article-id>
<article-categories>
<subj-group specific-use="electronic" subj-group-type="category">
<subject>Research</subject>
</subj-group>
<subj-group specific-use="print" subj-group-type="domain">
<subject>Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Investigation</subject>
</subj-group>
<subj-group subj-group-type="online-first">
<subject>Online First</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association Between Mitochondrial DNA Haplogroup Variation and Autism
Spectrum Disorders</article-title>
<alt-title alt-title-type="headline">Association Between Haplogroup Variation and Autism
Spectrum Disorders</alt-title>
<alt-title alt-title-type="running-head">Association Between Haplogroup Variation and Autism
Spectrum Disorders</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chalkia</surname>
<given-names>Dimitra</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi170065aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Larry N.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leipzig</surname>
<given-names>Jeremy</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="yoi170065aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lvova</surname>
<given-names>Maria</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="yoi170065aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Derbeneva</surname>
<given-names>Olga</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lakatos</surname>
<given-names>Anita</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hadley</surname>
<given-names>Dexter</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hakonarson</surname>
<given-names>Hakon</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wallace</surname>
<given-names>Douglas C.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi170065aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi170065aff6">
<sup>6</sup>
</xref>
</contrib>
</contrib-group>
<aff id="yoi170065aff1"><label>1</label>Center for Mitochondrial and Epigenomic Medicine,
Children’s Hospital of Philadelphia Research Institute, Philadelphia,
Pennsylvania</aff>
<aff id="yoi170065aff2"><label>2</label>Department of Biomedical and Health Informatics,
Children’s Hospital of Philadelphia Research Institute, Philadelphia,
Pennsylvania</aff>
<aff id="yoi170065aff3"><label>3</label>Center for Systems Biomedicine, Division of Digestive
Diseases, School of Medicine, University of California, Los Angeles</aff>
<aff id="yoi170065aff4"><label>4</label>Institute of Memory Impairments and Neurological
Disorders, Department of Neurobiology and Behavior, University of California, Irvine</aff>
<aff id="yoi170065aff5"><label>5</label>Center for Applied Genomics, Department of Pediatrics,
Children’s Hospital of Philadelphia Research Institute, Philadelphia,
Pennsylvania</aff>
<aff id="yoi170065aff6"><label>6</label>Department of Pathology and Laboratory Medicine,
University of Pennsylvania, Philadelphia</aff>
<author-notes>
<title>Article Information</title>
<corresp id="yoi170065cor1"><bold>Corresponding Author:</bold> Douglas C. Wallace, PhD,
Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia,
Department of Pathology and Laboratory Medicine, University of Pennsylvania, 3501 Civic
Center Blvd, Colket Translational Research Bldg, Room 6060, Philadelphia, PA 19104 (<email xlink:href="wallaced1@email.chop.edu">wallaced1@email.chop.edu</email>).</corresp>
<p><bold>Accepted for Publication:</bold> July 6, 2017.</p>
<p><bold>Correction: </bold>This article was corrected on October 4, 2017, to fix a missing
degree in the author byline. </p>
<p content-type="published-online"><bold>Published Online:</bold> August 23, 2017.
doi:<uri content-type="doi">10.1001/jamapsychiatry.2017.2604</uri></p>
<p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Singh and
Wallace had full access to all of the data in the study and take responsibility for the
integrity of the data and the accuracy of the data analysis. Drs Chalkia and Singh served
as co–first authors and contributed equally to the work.</p>
<p><italic>Study concept and design: </italic>Chalkia, Singh, Derbeneva, Wallace.</p>
<p><italic>Acquisition, analysis, or interpretation of data: </italic>All authors.</p>
<p><italic>Drafting of the manuscript: </italic>Chalkia, Singh, Wallace.</p>
<p><italic>Critical revision of the manuscript for important intellectual content:</italic>
All authors.</p>
<p><italic>Statistical analysis: </italic>Chalkia, Singh, Leipzig, Lakatos, Wallace.</p>
<p><italic>Obtained funding: </italic>Wallace.</p>
<p><italic>Administrative, technical, or material support: </italic>Chalkia, Lvova,
Derbeneva, Hadley, Wallace.</p>
<p><italic>Study supervision: </italic>Hakonarson, Wallace.</p>
<p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> None
reported.</p>
<p content-type="funding-statement"><bold>Funding/Support:</bold> This work was supported by
grants MH108592, NS021328, and NS070298 from the <funding-source rid="sp1">National
Institutes of Health</funding-source> and grant 205844 from the <funding-source rid="sp2">Simons Foundation</funding-source> (Dr Wallace).</p>
<p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and
conduct of the study; collection, management, analysis, and interpretation of the data;
preparation, review, or approval of the manuscript; and decision to submit the manuscript
for publication.</p>
</author-notes>
<pub-date iso-8601-date="2017-08-23T10:00" pub-type="epub">
<day>23</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ecorrected">
<day>4</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>8</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>74</volume>
<issue>11</issue>
<fpage>1161</fpage>
<lpage>1168</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="final">
<day>4</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright 2017 American Medical Association. All Rights
Reserved.</copyright-statement>
</permissions>
<self-uri content-type="pdf-version" xlink:href="jamapsychiatry-74-1161.pdf">jamapsychiatry-74-1161.pdf</self-uri>
<self-uri content-type="roundpoint" xlink:href="http://app.jamanetwork.com/?doi=10.1001/jamapsychiatry.2017.2604"></self-uri>
<self-uri content-type="silverchair" xlink:href="http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2017.2604"></self-uri>
<related-article ext-link-type="doi" id="d35e313" related-article-type="correction-forward" specific-use="electronic" xlink:href="10.1001/jamapsychiatry.2017.3229"></related-article>
<abstract abstract-type="teaser">
<p>This cohort study assesses what impact mitochondrial DNA haplogroup variation has on risk
of autism spectrum disorders.</p>
</abstract>
<abstract abstract-type="key-points">
<title>Key Points</title>
<sec id="ab-yoi170065-1">
<title>Question</title>
<p>Is there an association between mitochondrial DNA haplogroup-linked functional variants
and risk of autism spectrum disorders (ASD)?</p>
</sec>
<sec id="ab-yoi170065-2">
<title>Findings</title>
<p>In this study, based on 1624 patients with ASD and 2417 healthy parents and siblings
from 933 Autism Genetic Resource Exchange families, individuals with European
haplogroups I, J, K, O-X, T, and U and Asian and Native American haplogroups A and M are
at significantly increased risk of ASD compared with the most common European haplogroup
HHV.</p>
</sec>
<sec id="ab-yoi170065-3">
<title>Meaning</title>
<p>Functional mitochondrial DNA variants associated with haplogroups may contribute to the
risk for ASD, supporting the role of mitochondrial dysfunction in ASD.</p>
</sec>
</abstract>
<abstract>
<sec id="ab-yoi170065-4">
<title>Importance</title>
<p>Autism spectrum disorders (ASD) are characterized by impairments in social interaction,
communication, and repetitive or restrictive behavior. Although multiple physiologic and
biochemical studies have reported defects in mitochondrial oxidative phosphorylation in
patients with ASD, the role of mitochondrial DNA (mtDNA) variation has remained
relatively unexplored.</p>
</sec>
<sec id="ab-yoi170065-5">
<title>Objective</title>
<p>To assess what impact mitochondrial lineages encompassing ancient mtDNA functional
polymorphisms, termed haplogroups, have on ASD risk.</p>
</sec>
<sec id="ab-yoi170065-6">
<title>Design, Setting, and Participants</title>
<p>In this cohort study, individuals with autism and their families were studied using the
Autism Genetic Resource Exchange cohort genome-wide association studies data previously
generated at the Children’s Hospital of Philadelphia. From October 2010 to January
2017, we analyzed the data and used the mtDNA single-nucleotide polymorphisms
interrogated by the Illumina HumanHap 550 chip to determine the mtDNA haplogroups of the
individuals. Taking into account the familial structure of the Autism Genetic Resource
Exchange data, we then determined whether the mtDNA haplogroups correlate with ASD
risk.</p>
</sec>
<sec id="ab-yoi170065-7">
<title>Main Outcomes and Measures</title>
<p>Odds ratios of mitochondrial haplogroup as predictors of ASD risk.</p>
</sec>
<sec id="ab-yoi170065-8">
<title>Results</title>
<p>Of 1624 patients with autism included in this study, 1299 were boys (80%) and 325 were
girls (20%). Families in the Autism Genetic Resource Exchange collection (933 families,
encompassing 4041 individuals: 1624 patients with ASD and 2417 healthy parents and
siblings) had been previously recruited in the United States with no restrictions on
age, sex, race/ethnicity, or socioeconomic status. Relative to the most common European
haplogroup HHV, European haplogroups I, J, K, O-X, T, and U were associated with
increased risk of ASD, as were Asian and Native American haplogroups A and M, with odds
ratios ranging from 1.55 (95% CI, 1.16-2.06) to 2.18 (95% CI, 1.59-3) (adjusted
<italic>P</italic> &lt; .04). Hence, mtDNA haplogroup variation is an important risk
factor for ASD.</p>
</sec>
<sec id="ab-yoi170065-9">
<title>Conclusions and Relevance</title>
<p>Because haplogroups I, J, K, O-X, T, and U encompass 55% of the European population,
mtDNA lineages must make a significant contribution to overall ASD risk.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source id="sp1">National Institutes of Health</funding-source>
</award-group>
<award-group>
<funding-source id="sp2">Simons Foundation</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>